CytRx Corporation (Nasdaq: CYTR) announced that the independent Data Safety Monitoring Committee (DSMC) overseeing the Company’s international Phase 2b clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE